Andjelic, S <br/><br/>
Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Oct 2000 
 - 3860-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.165.7.3860  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--immunology<br/>B-Lymphocytes--cytology<br/>Biological Transport--immunology<br/>CD40 Antigens--immunology<br/>Cell Cycle Proteins<br/>Cell Division--drug effects<br/>Cell Nucleus--immunology<br/>Cell Separation<br/>Cell Survival--immunology<br/>Cells, Cultured<br/>Chromones--pharmacology<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Down-Regulation--immunology<br/>Enzyme Activation--immunology<br/>Enzyme Inhibitors--pharmacology<br/>Growth Inhibitors--antagonists & inhibitors<br/>Immune Sera--pharmacology<br/>Mice<br/>Mice, Knockout<br/>Microtubule-Associated Proteins--antagonists & inhibitors<br/>Morpholines--pharmacology<br/>NF-kappa B--metabolism<br/>Phosphatidylinositol 3-Kinases--deficiency<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation<br/>Protein Serine-Threonine Kinases<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-rel--deficiency<br/>Signal Transduction--drug effects<br/>Tumor Suppressor Proteins<br/>bcl-X Protein